Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aytu Biopharma Inc
(NQ:
AYTU
)
2.440
UNCHANGED
Streaming Delayed Price
Updated: 12:09 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,553
Open
2.440
Bid (Size)
2.410 (1)
Ask (Size)
2.470 (8)
Prev. Close
2.440
Today's Range
2.430 - 2.471
52wk Range
1.520 - 3.500
Shares Outstanding
5,567,490
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Sidoti Events, LLC's Virtual August Micro-Cap Conference
August 13, 2024
Via
ACCESSWIRE
Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024
August 08, 2024
Via
ACCESSWIRE
Performance
YTD
-15.57%
-15.57%
1 Month
-9.63%
-9.63%
3 Month
-23.51%
-23.51%
6 Month
-15.57%
-15.57%
1 Year
+45.24%
+45.24%
More News
Read More
Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations
August 06, 2024
Via
ACCESSWIRE
Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms
June 18, 2024
Via
ACCESSWIRE
Lytham Partners Spring 2024 Investor Conference Starts Tomorrow, May 30, 2024
May 29, 2024
Via
Newsfile
Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024
April 03, 2024
Via
ACCESSWIRE
Earnings Scheduled For February 14, 2024
February 14, 2024
Via
Benzinga
Earnings Preview: Aytu BioPharma
February 13, 2024
Via
Benzinga
Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023
November 30, 2023
Via
ACCESSWIRE
Aytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
May 23, 2024
Via
ACCESSWIRE
AYTU Stock Earnings: Aytu BioPharma Beats EPS, Beats Revenue for Q3 2024
May 15, 2024
Via
InvestorPlace
Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024
May 08, 2024
Via
ACCESSWIRE
Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter
February 14, 2024
Via
ACCESSWIRE
Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024
February 07, 2024
Via
ACCESSWIRE
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
November 14, 2023
Via
ACCESSWIRE
Aytu BioPharma's Earnings: A Preview
November 13, 2023
Via
Benzinga
Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year
November 08, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement
October 26, 2023
Via
ACCESSWIRE
Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
January 23, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 22, 2023
Via
Benzinga
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 15, 2023
Via
Benzinga
Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023
November 07, 2023
Via
ACCESSWIRE
Biggest Short Squeeze Stocks Of The Week: Biotech Stocks Dominate, A Bitcoin-Related Stock Moves Up Leaderboard
November 06, 2023
Via
Benzinga
Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023
October 09, 2023
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.